利用行为经济学策略缩小生物医学艾滋病预防方面的差距。

IF 15.8 1区医学 Q1 Medicine

PLoS Medicine Pub Date : 2024-10-24 eCollection Date: 2024-10-01 DOI:10.1371/journal.pmed.1004475

Jesse Heitner, Valerian Mwenda, Grace Umutesi, Ruanne V Barnabas

引用次数: 0

摘要

由于经济贫困和年龄差异关系等多重因素，南部非洲的少女和年轻女性（AGYW）面临的艾滋病发病率是男性同龄人的三倍。Aurélia Lépine 及其同事的一项新研究表明，解决少女和年轻女性的医疗费用问题有可能降低艾滋病的发病率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Leveraging behavioral economics strategies to close gaps in biomedical HIV prevention.

Adolescent girls and young women (AGYW) in southern Africa face triple the HIV incidence of their male peers due to multiple factors, including economic deprivation and age-disparate relationships. A new study by Aurélia Lépine and colleagues has demonstrated that addressing healthcare costs among AGYW has the potential to reduce HIV incidence.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

PLoS Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

17.60

自引率

0.60%

发文量

227

审稿时长

4-8 weeks

期刊介绍： PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.